Lv41
790 积分 2022-07-26 加入
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: First-in-human dose-escalation study
2小时前
已完结
Review of Dose Justifications for Antibody-Drug Conjugate Approvals from Clinical Pharmacology Perspective: a Focus on Exposure-Response Analyses
26天前
已完结
A compartmental absorption and transit model for estimating oral drug absorption
2个月前
已完结
Polar molecular surface properties predict the intestinal absorption of drugs in humans
2个月前
已完结
Prediction of Intestinal First-Pass Drug Metabolism
2个月前
已完结
Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer
2个月前
已完结
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer
2个月前
已完结
Interspecies scaling of renally secreted drugs
2个月前
已完结
PREDICTION OF ABSOLUTE BIOAVAILABILITY FOR DRUGS USING ORAL AND RENAL CLEARANCE FOLLOWING A SINGLE ORAL DOSE: A CRITICAL VIEW
2个月前
已完结
Response to the comments on the commentary ‘prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical view’
2个月前
已完结
皖公网安备34019202002308
